15 results
20-F
2021 FY
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
AND PROCEDURES.
ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT.
ITEM 16B. CODE OF ETHICS.
ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES.
ITEM 16D … and training suitable clinical investigators;
delays in obtaining required ethics committee or institutional review board, or IRB, approval at each
424B4
CNTB
Connect Biopharma Holdings Ltd
19 Mar 21
Prospectus supplement with pricing info
4:49pm
requirements, regulations or guidelines, and are subject to oversight by these governmental agencies and ethics committees or IRBs at the medical … procedures, the occurrence of which could affect the integrity of clinical trial data;
delays in necessary interactions with regulators, ethics committees
F-1MEF
EX-8.2
CNTB
Connect Biopharma Holdings Ltd
18 Mar 21
Registration statement to add securities to prior F-1 registration
9:02pm
the concepts of public interests, social ethics, national security, good faith, fair dealing, and applicable statutes of limitation; (ii) any
F-1/A
pxyammvf0zomjh5dc
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
fepmyxj9otpc1mll
17 Mar 21
Registration statement (foreign) (amended)
6:38am
F-1/A
EX-99.2
m7t qydg3t1nh
17 Mar 21
Registration statement (foreign) (amended)
6:38am
F-1/A
EX-99.2
a1kswwky3 uu3u
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
0fd363e
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-99.1
aiut536y
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
ojd7 tr4os
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-99.2
dsm46bq4ju0d
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
2efto64agtds9jmkj
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
vhekvs
17 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next